Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association

$RDGTPress releaseJul 24, 2026, 8:30 AM ETRead the release

Ridgetech's subsidiary Zhejiang Jiuxin Medicine was elected as a vice-president unit of the Hangzhou Qiantang District Biomedical and Cosmetic High-Quality Development Association, scheduled for official inauguration on July 28, 2026. The appointment recognizes Jiuxin Medicine's implementation of full-variety drug traceability code scanning across Zhejiang Province, following an inspection by the Zhejiang Medical Products Administration in March 2026.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    RDGT: Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association — AI Analysis | Signal8